EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects

Xuanru Ren, Jun Zhang, Luya Wang, Yuxuan Zhang, Jialu Li, Hao Yu, Zhaohai Zheng, Yiqing Zhang, Hesong Zeng, Yan Chen, Junfang Wu

Journal of Clinical Lipidology · 2025

DOI: 10.1016/j.jacl.2024.09.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Xuanru Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuha…. Hauptthemen laut MEDLINE: Phytosterols, Lipid Metabolism, Inborn Errors, Hypercholesterolemia, Intestinal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Province Natural Science Foundation, National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients suffering from sitosterolemia with ABCG5/8 mutation typically present with early-onset or rapidly progressive atherosclerosis. Their kindreds with partial genetic deficiencies of ABCG5/8 are often considered healthy. However, discerning sitosterolemia from its familial kindreds and hyperlipidemia subjects has remained challenging. METHODS: Here we retrospectively recruited 7 families including 8 individuals diagnosed with sitosterolemia subjects, and 14 kindreds carrying single gene mutations. Additionally, 17 individuals with hyperlipidemia and 130 healthy controls served as positive and negative controls, respectively. A total of 6 phytosterols combined with cholesterol absorption indices (including sitosterol, campesterol, stigmasterol, and cholestanol) and cholesterol synthesis markers (desmosterol and 7-dehydrocholesterol), was compared across the aforementioned 4 groups. RESULTS: As expected, the sitosterolemia subjects with double mutations demonstrated significantly elevated levels of sitosterol and other cholesterol absorption indices. Meanwhile, sitosterolemia kindreds with single gene mutation showed a similar pattern of activated cholesterol-absorption ability to the hyperlipidemia group, but not as high as the double mutation group. Notably, the cholesterol-synthesis enzyme 7-dehydrocholesterol reductase displayed an increase in the hyperlipidemia group but a decrease in the sitosterolemia kindred group, suggesting a potential discriminative role of 7-dehydrocholesterol in distinguishing between these 2 groups. The combination of phytosterols was more valuable than clinical lipid index for sitosterolemia diagnosis. CONCLUSION: Our study revealed mild disruptions of cholesterol absorption capacities in sitosterolemia kindreds with single mutations. Furthermore, the combination of 6 phytosterols proved effective in distinguishing between sitosterolemia, its single mutation carriers, and hyperlipidemia patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytosterolsLipid Metabolism, Inborn ErrorsHypercholesterolemiaIntestinal DiseasesHyperlipidemiasHumansMaleFemaleAdultMiddle AgedATP Binding Cassette Transporter, Subfamily G, Member 5ATP Binding Cassette Transporter, Subfamily G, Member 8CholesterolMutationRetrospective StudiesSitosterolsYoung AdultAgedPedigreeLipoproteins

Stichwörter der Autor:innen

HyperlipidemiaKindredPhytosterolsSingle mutation carrierSitosterolemia

Substanzen

PhytosterolsATP Binding Cassette Transporter, Subfamily G, Member 5ATP Binding Cassette Transporter, Subfamily G, Member 8ABCG5 protein, humanABCG8 protein, humanCholesterolSitosterolsLipoproteins

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Key Laboratory of Genetics and Molecular Mechanisms of…
  • The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China (Drs J. Zhang, Li, Yu, Zheng, Yiqing Zhang, and Chen). Electronic…
  • Beijing Anzhen Hospital, Capital Medical University, Department of Atherosclerosis, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China (Dr Wang). Electronic address: wangluya@126.com.
  • The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China (Drs J. Zhang, Li, Yu, Zheng, Yiqing Zhang, and Chen); The First A…

Förderung

  • National Natural Science Foundation of China
  • Hubei Province Natural Science Foundation
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Ren, X., Zhang, J., Wang, L., Zhang, Y., Li, J., Yu, H., Zheng, Z., Zhang, Y., Zeng, H., Chen, Y., & Wu, J. (2025). Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2024.09.002

Vancouver

Ren X, Zhang J, Wang L, Zhang Y, Li J, Yu H, et al. Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2024.09.002

BibTeX
@article{Ren2025,
  author = {Ren, Xuanru and Zhang, Jun and Wang, Luya and Zhang, Yuxuan and Li, Jialu and Yu, Hao and Zheng, Zhaohai and Zhang, Yiqing and Zeng, Hesong and Chen, Yan and Wu, Junfang},
  title = {Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects},
  journal = {Journal of Clinical Lipidology},
  year = {2025},
  doi = {10.1016/j.jacl.2024.09.002}
}
Kostenlos starten →